FrancophonIA/ELRC3.0 huggingface dataset:
English: Cardiac disorders Rare cases of myocardial infarction have been reported.
Danish: Hjerte Sjældne tilfælde af myokardieinfarkt er rapporteret.
English: In study TAX316, alopecia persisting into the follow-up period after the end of chemotherapy was reported in 687 TAC patients and 645 FAC patients.
Danish: I studiet TAX 316 blev alopecia, der persisterede ind i follow-up perioden efter endt kemoterapi, rapporteret hos hos 687 TAC-patienter og 645 FAC-patienter.
English: Clearance of docetaxel in combination therapy with cisplatin was similar to that observed following monotherapy.
Danish: Docetaxels clearance i kombinationsterapi med cisplatin var sammenlignelig med det observerede ved monoterapi.
English: Docetaxel has been shown to be mutagenic in the in vitro micronucleus and chromosome aberration test in CHO-K1 cells and in the in vivo micronucleus test in the mouse.
Danish: Docetaxel har vist sig at være mutagent in vitro i mikronucleus- og kromosom-aberrationstesten i CHO-K1-celler, samt in vivo i mikronucleustesten i mus.
English: Mild to moderate neuro-sensory signs are characterised by paresthesia, dysesthesia or pain including burning.
Danish: Milde til moderate neurosensoriske symptomer er karakteriseret ved paræstesi, dysæstesi eller smerter inklusive brændende fornemmelser.
English: Previous chemotherapy should have included an anthracycline or an alkylating agent.
Danish: I tidligere kemoterapi skal anthracyklin eller et alkylerende stof have været anvendt.
English: • 332 patients who received docetaxel in combination with prednisone or prednisolone (clinically important treatment related adverse events are presented).
Danish: 332 patienter, som fik docetaxel i kombination med prednison eller prednisolon (klinisk relevante behandlingsrelaterede bivirkninger er medtaget).
English: Although the possible in vivo interaction of docetaxel with concomitantly administered medicinal products has not been investigated formally, in vitro interactions with tightly protein-bound drugs such as erythromycin, diphenhydramine, propranolol, propafenone, phenytoin, salicylate, sulfamethoxazole and sodium valproate did not affect protein binding of docetaxel.
Danish: Skønt mulige in vivo-interaktioner mellem docetaxel og anden samtidigt administreret lægemiddel ikke er undersøgt formelt, har in vitrointeraktionsstudier med kraftigt proteinbundne stoffer såsom erythromycin, difenhydramin, propranolol, propafenon, fenytoin, salicylat, sulfamethoxazol og natriumvalproat, ikke påvirket docetaxels proteinbinding.
English: More grade 3/4 adverse events were observed for docetaxel monotherapy (55.4%) compared to paclitaxel (23.0%).
Danish: Flere grad 3/4 bivirkninger blev observeret for docetaxel monoterapi (55,4 %) sammenlignet med paclitaxel (23,0 %).
English: You must not breast-feed while you are treated with Docetaxel Teva Pharma.
Danish: Du må ikke amme, mens du behandles med Docetaxel Teva Pharma.
English: These reactions were described using the NCI Common Toxicity Criteria (grade 3 = G3; grade 3-4 = G3/4; grade 4 = G4) and the COSTART and the MedRA terms.
Danish: Disse reaktioner blev beskrevet under brug af NCI Common Toxicity Criteria (grad 3 = G3; grad 3-4 = G3/4; grad 4 = G4) og COSTART-termerne og MedDRA-termerne.
English: Docetaxel is more than 95% bound to plasma proteins.
Danish: Docetaxels plasmaproteinbinding er mere end 95 %.
English: This is because Docetaxel Teva Pharma or the other medicine may not work as well as expected and you may be more likely to get a side effect.
Danish: Dette er fordi Docetaxel Teva Pharma eller den anden medicin måske ikke virker så godt som forventet, og du måske lettere får bivirkninger.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 21st January 2011
Danish: DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF
English: There is no relevant use of Docetaxel Teva Pharma in the paediatric population in the indications breast cancer, non-small cell lung cancer and prostate cancer.
Danish: Der er ingen relevant anvendelse af docetaxel Teva Pharma i den pædiatriske population til indikationerne brystkræft, ikke-småcellet lungekræft og prostatakræft.
English: The most commonly reported adverse reactions of Docetaxel Teva Pharma alone are: decrease in the number of red blood cells or white blood cells, alopecia, nausea, vomiting, sores in the mouth, diarrhoea and tiredness.
Danish: De mest almindelige bivirkninger ved Docetaxel Teva Pharma givet alene er: fald i antallet af røde og hvide blodlegemer, hårtab, kvalme, opkastning, sår i munden, diarré og træthed.
English: In particular, please inform your doctor in case of diarrhoea, sores in the mouth, feeling of numbness or pins and needles, fever and give her/him results of your blood tests.
Danish: Kontakt specielt lægen, hvis du får diarré, sår i munden, følelsesløshed, stikken og prikkende fornemmelser eller feber, og giv lægen resultatet af dine blodprøver.
English: Do not store above 25°C .
Danish: Må ikke opbevares ved temperaturer over 25 °C.
English: Docetaxel Teva Pharma vials should not be stored above 25°C and should be protected from light.
Danish: Docetaxel Teva Pharma hætteglas må ikke opbevares ved temperaturer over 25 ºC og skal beskyttes mod lys.
English: Lacrimation increased; Conjunctivitis
Danish: Forhøjet tåresekretion; Konjunktivitis
English: If you are a man being treated with Docetaxel Teva Pharma you are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment because docetaxel may alter male fertility.
Danish: Hvis du er mand og i behandling med Docetaxel Teva Pharma, rådes du til ikke at blive far til et barn under og 6 måneder efter behandlingen og til at søge vejledning om opbevaring af sæd inden behandlingen, fordi docetaxel kan nedsætte den mandlige fertilitet.
English: For cisplatin dose adjustments, see the corresponding summary of product characeteristics.
Danish: For cisplatin-dosisjustering se tilsvarende produktresumé.
English: A total of 449 patients were randomized to receive either docetaxel monotherapy 100 mg/m² as a 1 hour infusion or paclitaxel 175 mg/m² as a 3 hour infusion.
Danish: 449 patienter blev randomiseret til enten at modtage docetaxel monoterapi 100 mg/m givet som 1 times infusion eller paclitaxel 175 mg/m givet som en infusion over 3 timer.
English: Treatment difference: 6.2% [95% CI: 0.2; 12.3]
Danish: Behandlingsforskel: 6,2 % [95 % CI: 0,2; 12,3]
English: This medicine should not be used after the expiry date which is stated on the carton and vials.
Danish: Brug ikke dette lægemiddel efter den udløbsdato, der står på pakningen og hætteglassene.
English: Docetaxel increased response rate (33% vs. 12%, p<0.0001), prolonged time to progression (19 weeks vs. 11 weeks, p=0.0004) and prolonged overall survival (11 months vs. 9 months, p=0.01).
Danish: Docetaxel øgede responsraten (33 % mod 12 %, p < 0,0001), forlængede tiden til progression (19 uger mod 11 uger, p = 0,0004), samt forlængede overlevelsen (11 måneder mod 9 måneder, p = 0,01).
English: Please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Danish: Fortæl det altid til lægen eller hospitalsfarmaceut, hvis du bruger anden medicin eller har brugt det for nylig.
English: For the treatment of patients with locally advanced or metastatic breast cancer, the recommended dose of docetaxel is 100 mg/m2 in monotherapy.
Danish: Til behandling af patienter med lokalt fremskreden eller metastatisk brystkræft er den anbefalede dosis docetaxel i monoterapi 100 mg/m
English: Remove the syringe and needle and mix manually by repeated inversions for at least 45 seconds.
Danish: Fjern sprøjten og bland miksturen manuelt ved at vende hætteglasset gentagne gange i mindst 45 sekunder.
English: Docetaxel must not be used in patients with baseline neutrophil count of <1,500 cells/mm3.
Danish: Docetaxel må ikke anvendes hos patienter med en udgangsværdi for neutrofile granulocytter på < 1.500 celler/mm
English: Treatment difference: 5.4% [95% CI: -1.1; 12.0]
Danish: Behandlingsforskel: 5,4 % [95 % CI: -1,1; 12,0]
English: Clinical cases consistent with an increase in docetaxel toxicity were reported when it was combined with ritonavir.
Danish: Der er rapporteret kliniske tilfælde, hvor der var en tilsvarende stigning i docetaxels toksicitet, når det blev kombineret med ritonavir.
English: Peripheral sensory neuropathy was observed to be ongoing during follow-up in 10 patients out of the 84 patients with peripheral sensory neuropathy at the end of the chemotherapy in the node positive breast cancer study (TAX316).
Danish: Perifer sensorisk neuropati fortsatte under opfølgning hos 10 patienter ud af 84 patienter med perifersensorisk neuropati ved slutningen af kemoterapien i det lymfeknude-positive brystkræftstudie (TAX316).
English: • interstitial lung disease (inflammation of the lungs causing coughing and difficulty breathing.
Danish: Interstitiel lungesygdom (betændelse i lungerne, der forårsager hoste og vejrtrækningsbesvær.
English: Following the administration of a 100 mg/m2 dose given as a one hour infusion a mean peak plasma level of 3.7 μg/ml was obtained with a corresponding AUC of 4.6 h.μg/ml.
Danish: Efter administration af docetaxel 100 mg/m givet som infusion over 1 time fandtes den gennemsnitlige maksimale plasmakoncentration at være 3,7 mg/ml med et AUC på 4,6 h.μg/ml.
English: Headache (G3/4: <1%); Neuropathy peripheral
Danish: Hovedpine (G3/4: < 1 %); Perifer neuropati
English: The severity of adverse events of Docetaxel Teva Pharma may be increased when Docetaxel Teva Pharma is given in combination with other chemotherapeutic agents.
Danish: Alvorligheden af bivirkningerne ved Docetaxel Teva Pharma kan forøges, når Docetaxel Teva Pharma gives i kombination med andre kemoterapeutiske lægemidler.
English: Therefore, men being treated with docetaxel are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment.
Danish: Mænd, som er i behandling med docetaxel, tilrådes derfor ikke at blive fædre til børn under og op til 6 måneder efter behandling, samt til at søge vejledning vedrørende opbevaring af sæd inden behandling.
English: TEVA Pharmaceutical Works Private Limited Company Táncsics Mihály út 82
Danish: TEVA Pharmaceutical Works Private Limited Company
English: Consequently, because of the potential for adverse reactions in nursing infants, breast feeding must be discontinued for the duration of docetaxel therapy.
Danish: På grund af risiko for skadelige påvirkninger af barnet, skal amning derfor ophøre under behandling med docetaxel.
English: In the docetaxel, doxorubicin and cyclophosphamide (TAC) treated patients, the risk of delayed myelodysplasia or myeloid leukaemia requires haematological follow-up.
Danish: For patienter, behandlet med docetaxel, doxorubicin og cyclofosfamid (TAC), kræver risikoen for forsinket myelodysplasi eller myolid leukæmi hæmatologisk opfølgning.
English: Neutropenic infection Neutropenic infection (Grade 3-4)
Danish: Neutropenisk infektion (grad 3
English: • swelling caused by faulty lymphatic drainage
Danish: Hævelse forårsaget af mangelfuld drænage af lymfe
English: Docetaxel Teva Pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.
Danish: Docetaxel Teva Pharma i kombination med prednison eller prednisolon er indiceret til behandling af patienter med hormonrefraktær metastatisk prostatakræft.
English: • 174 and 251 head and neck cancer patients who received docetaxel in combination with cisplatin and 5-fluorouracil (clinically important treatment related adverse events are presented).
Danish: 174 og 251 hoved- og halskræftpatienter, som blev behandlet med docetaxel i kombination med cisplatin og 5-fluoruracil (klinisk vigtige behandlingsrelaterede bivirkninger er nævnt).
English: Ask your pharmacist how to throw away medicines no longer used.
Danish: Spørg på apoteket, hvordan du skal bortskaffe medicinrester.
English: There was an increased incidence of SAEs (40% vs. 31%) and Grade 4 AEs (34% vs. 23%) in the trastuzumab combination arm compared to docetaxel monotherapy.
Danish: Der var en forøget forekomst af meget alvorlige bivirkninger (40 % mod 31 %) og grad 4 alvorlige bivirkninger (34 % mod 23 %) i kombinationsarmen trastuzumab sammenlignet med docetaxelenkeltbehandling.
English: There are limited data available in patients > 70 years of age on docetaxel use in combination with doxorubicin and cyclophosphamide.
Danish: Der er begrænsede tilgængelige data vedrørende anvendelse af docetaxel i kombination med doxorubicin og cyclofosfamid til patienter over 70 år.
English: There was less use of morphinic analgesic (p<0.01), non-morphinic analgesics (p<0.01), other disease related medications (p=0.06) and radiotherapy (p<0.01) in patients treated with docetaxel at 75 mg/m² compared to those with BSC.
Danish: Der var mindre brug af smertestillende morfika (p < 0,01), smertestillende ikke-morfika (p < 0,01), anden sygdomsrelateret medicin (p = 0,06) og strålebehandling (p < 0,01) hos de patienter, der fik behandling med docetaxel ved doseringen 75 mg/m end hos patienterne, der fik bedste palliative behandling.
English: • feeling of numbness or pins and needles or pain in the joints or muscles
Danish: Følelsesløshed eller stikkende og prikkende fornemmelse eller smerter i led eller muskler
English: Preparation of the Docetaxel Teva Pharma premix solution (10 mg docetaxel/ml)
Danish: 4.1 Fremstilling af Docetaxel Teva Pharma præmixopløsning (10 mg docetaxel/ml)
English: The name of this medicine is Docetaxel Teva Pharma.
Danish: Medicinen hedder Docetaxel Teva Pharma.
English: To be administered under the supervision of a physician experienced in the use of cytotoxic agents
Danish: Skal gives under vejledning af en læge med erfaring i behandling med cytostatika
English: Among the 300 (221 patients in the phase III part of the study and 79 patients in the phase II part) patients treated with docetaxel in combination with cisplatin and 5-fluorouracil in the gastric cancer study, 74 were 65 years of age or older and 4 patients were 75 years of age or older.
Danish: Blandt 300 patienter (221 patienter i fase III-delen af studiet og 79 patienter i fase II-delen af studiet), som fik behandling med docetaxel i kombination med cisplatin og 5-fluoruracil i studiet af gastrisk kræft, var 74 patienter 65 år eller ældre og 4 patienter var 75 år eller ældre.
English: In chemotherapy naïve patients treated for non-small cell lung cancer, the recommended dose regimen is docetaxel 75 mg/m2 immediately followed by cisplatin 75 mg/m2 over 30-60 minutes.
Danish: For patienter, der ikke tidligere er behandlet med kemoterapi, der behandles for ikke-småcellet lungekræft, er den anbefalede dosis af docetaxel 75 mg/m2, straks efterfulgt af cisplatin 75 mg/m givet over 30-60 minutter.
English: Based on extrapolation from a pharmacokinetic study with ketoconazole in 7 patients, consider a 50% docetaxel dose reduction if patients require coadministration of a strong CYP3A4 inhibitor such as azole antifungals, ritonavir and some macrolides (clarithromycin, telithromycin).
Danish: Baseret på ekstrapolation fra et farmakokinetisk studie med ketaconazol hos 7 patienter skal det overvejes at halvere dosis af docetaxel, hvis patienten samtidig skal behandles med en stærk CYP3A4-hæmmer, såsom azolsvampemidler, ritonavir eller visse makrolider (clarithromycin, telithromycin).
English: The pharmacokinetics of docetaxel have been evaluated in cancer patients after administration of 20-115 mg/m2 in Phase I studies.
Danish: Fase I-studier har undersøgt docetaxels farmakokinetiske egenskaber hos kræftpatienter efter indgift af 20-115 mg/m2.
English: In study GEICAM 9805, lymphoedema was observed to be ongoing in 4 of the 5 patients with lymphoedema at the end of the chemotherapy.
Danish: I studiet GEICAM 9805 fortsatte lymfødem hos 4 ud af 5 patienter med lymfødem ved slutningen af kemoterapien.
English: 4.2.5 As with all parenteral products, Docetaxel Teva Pharma premix solution and infusion solution should be visually inspected prior to use, solutions containing a precipitate should be discarded.
Danish: 4.2.5 Som alle andre parenterale præparater bør Docetaxel Teva Pharma præmixopløsning og infusionsvæske inspiceres visuelt inden brug, og opløsninger med udfældning skal kasseres.
English: For treatment after failure of prior platinum-based chemotherapy, the recommended dose is 75 mg/m² as a single agent.
Danish: For behandling efter forudgående svigt af platinbaseret kemoterapi er den anbefalede dosis 75 mg/m
English: For combination with capecitabine, the most frequent treatment-related undesirable effects (≥ 5%) reported in a phase III study in breast cancer patients failing anthracycline treatment are presented (see capecitabine summary of product characteristics).
Danish: I kombination med capecitabin er de mest almindelige behandlingsrelaterede bivirkninger (≥ 5 %), som blev rapporteret i et fase III-studie med brystkræftpatienter, hvor anthracyklinbehandling ikke havde haft effekt, medtaget (se produktresuméet for capecitabin).
English: • Induction chemotherapy followed by radiotherapy (TAX 323) MedDRA system organ classes
Danish: Induktionskemoterapi efterfulgt af strålebehandling (TAX 323) Systemorganklasser i henhold til MedDRAdatabasen
English: Therefore, the recommended dose of docetaxel in those patients with elevated liver function test (LFTs) is 75 mg/m2 and LFTs should be measured at baseline and before each cycle (see section 4.2).
Danish: Derfor er den anbefalede dosis docetaxel 75mg/m til de patienter, der har forhøjet leverfunktionstest (LFT), og LFT skal måles ved start og før hver behandlingscyklus (se pkt.
English: Paresthesia; Headache; Dysgeusia;
Danish: Paræstesi; hovedpine; dysgeusi;
English: The pharmacokinetics of docetaxel, doxorubicin and cyclophosphamide were not influenced by their coadministration.
Danish: Co-administrationen af docetaxel, doxorubicin og cyclofosfamid påvirkede ikke deres farmakokinetik.
English: Inflammation of the lungs can also develop when docetaxel therapy is used with radiotherapy)
Danish: Betændelse i lungerne kan også udvikles, når docetaxelbehandling anvendes sammen med
English: The solvent for Docetaxel Teva Pharma is water for injections.
Danish: Solvens (opløsningsvæske) til Docetaxel Teva Pharma er vand til injektionsvæsker.
English: Rare cases of radiation pneumonitis have been reported in patients receiving concomitant radiotherapy.
Danish: Der er rapporter om sjældne tilfælde af strålingspneumonitis hos patienter, som modtog samtidig strålebehandling.
English: • Infusion solution: Chemical and physical in-use stability has been demonstrated for 4 hours at room temperature (below 25°C).
Danish: Infusionsopløsning: Kemisk og fysisk stabilitet under brug er påvist i 4 timer ved stuetemperatur (under 25 °C).
English: In patients treated with docetaxel in combination with doxorubicin and cyclophosphamide (TAC), febrile neutropenia and/or neutropenic infection occurred at lower rates when patients received primary G-CSF prophylaxis.
Danish: Hos patienter, der blev behandlet med docetaxel i kombination med doxorubicin og cyclofosfamid (TAC), opstod febril neutropeni og/eller neutropenisk infektion sjældnere, når patienterne fik primær G-CSF-profylakse.
English: Docetaxel Teva Pharma is supplied as single-dose vials.
Danish: Docetaxel Teva Pharma leveres som enkeltdosishætteglas.
English: Very rare cases of cutaneous lupus erythematous and bullous eruptions such as erythema multiform, Stevens-Johnson syndrome, toxic epidermal necrolysis, have been reported with docetaxel.
Danish: Med docetaxel er der rapporter om meget sjældne tilfælde af kutan erytematøs lupus, bulløst udslæt, såsom erythema multiforme, Stevens-Johnson syndrom og toksisk epidermal nekrolyse.
English: In a small number of patients (n=23) with clinical chemistry data suggestive of mild to moderate liver function impairment (ALT, AST ≥1.5 times the ULN associated with alkaline phosphatase ≥2.5 times the ULN), total clearance was lowered by 27% on average (see section 4.2).
Danish: Hos et beskedent antal patienter (n = 23) med en klinisk kemi, der tydede på en let til moderat nedsat leverfunktion (ALAT og ASAT ≥ 1,5 gange øvre normalværdi og basisk fosfatase ≥ 2,5 gange øvre normalværdi), var clearance nedsat med gennemsnitlig 27 % (se pkt.
English: • stomach upsets including nausea, vomiting and diarrhoea, constipation
Danish: Opstød fra maven, inklusive kvalme, opkastning og diarré, forstoppelse Mavesmerter
English: Without affecting overall survival time (docetaxel 15 months vs. doxorubicin 14 months, p=0.38) or time to progression (docetaxel 27 weeks vs. doxorubicin 23 weeks, p=0.54), docetaxel increased response rate (52% vs. 37%, p=0.01) and shortened time to response (12 weeks vs. 23 weeks, p=0.007).
Danish: Uden at påvirke overlevelsestiden (docetaxel 15 måneder mod doxorubicin 14 måneder, p = 0,38) eller tiden til progression (docetaxel 27 uger mod doxorubicin 23 uger, p = 0,54), øgede docetaxel responsraten (52 % mod 37 %, p = 0,01) og gav hurtigere respons (12 uger mod 23 uger, p = 0,007).
English: The infusion solution should be used within 4 hours at room temperature (below 25°C).
Danish: Infusionsvæsken skal bruges inden for 4 timer ved stuetemperatur (under 25 ºC).
English: In combination with cisplatin For patients who are dosed initially at docetaxel 75 mg/m2 in combination with cisplatin and whose nadir of platelet count during the previous course of therapy is < 25,000 cells/mm3, or in patients who experience febrile neutropenia, or in patients with serious non-haematologic toxicities, the docetaxel dose in subsequent cycles should be reduced to 65 mg/m2.
Danish: I kombination med cisplatin Hos patienter med en initialdosis på 75 mg/m i kombination med cisplatin med en minimum blodpladeværdi under den tidligere behandlingsrunde på < 25.000 celler/mm eller hos patienter, der får febril neutropeni, eller hos patienter med alvorlig, ikke-hæmatologisk toksicitet bør docetaxeldosis reduceres til 65 mg/m i de følgende behandlingsrunder.
English: ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1 97007 0
Danish: Arzneimittel Vertriebs-GmbH Tel: +43 1 97007 0
English: Inject the required premix volume into a non-PVC 250 ml infusion bag containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Danish: Injicer derefter den beregnede mængde præmix i en 250 ml ikke-pvc-infusionspose med enten 5 % glucoseinfusionsvæske eller natriumchloridinfusionsvæske 9 mg/ml (0,9 %).
English: A study of 14C-docetaxel has been conducted in three cancer patients.
Danish: C-mærket docetaxel på 3 kræftpatienter.
English: 2.1 Docetaxel 80 mg vial:
Danish: 2.1 Docetaxel 80 mg hætteglas:
English: Mean values for total body clearance and steady-state volume of distribution were 21 l/h/m2 and 113 l, respectively.
Danish: Gennemsnitsværdierne for den totale clearance og steady-state distributionsvolumen var henholdsvis 21 l/h/m og 113 l. Den interindividuelle variation i totalclearance var ca. 50 %.
English: 4.2.2 Inject the required premix volume into a 250 ml non-PVC infusion bag containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Danish: 4.2.2 Injicer derefter den beregnede mængde præmix i en 250 ml ikke-pvc-infusionspose med enten 5 % glucoseinfusionsvæske eller natriumchloridinfusionsvæske 9 mg/ml (0,9 %).
English: Reporting of side effects
Danish: Indberetning af mistænkte bivirkninger
English: • 406 patients who received docetaxel in combination with cisplatin.
Danish: 406 patienter, som fik docetaxel i kombination med cisplatin.
English: Each ml of concentrate contains 27.73 mg docetaxel.
Danish: Én ml koncentrat indeholder 27,73 mg docetaxel.
English: CAUTION: Dilution of concentrate required using the entire contents of the solvent vial.
Danish: BEMÆRK: Skal fortyndes med hele indholdet fra hætteglasset med solvens.
English: b) Preparation of the infusion solution
Danish: b) Tilberedning af infusionsvæsken